BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6133577)

  • 1. Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis.
    Delamere JP; Farr M; Grindulis KA
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1547-8. PubMed ID: 6133577
    [No Abstract]   [Full Text] [Related]  

  • 2. Fenclofenac-induced selective IgA deficiency in rheumatoid arthritis.
    Farr M; Struthers GR; Scott DG; Bacon PA
    Br J Rheumatol; 1985 Nov; 24(4):367-9. PubMed ID: 4063627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodeficiencies associated with sulphasalazine therapy in inflammatory arthritis.
    Farr M; Kitas GD; Tunn EJ; Bacon PA
    Br J Rheumatol; 1991 Dec; 30(6):413-7. PubMed ID: 1684124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphasalazine induced immunodeficiency.
    Savilahti E
    Br Med J (Clin Res Ed); 1983 Sep; 287(6394):759. PubMed ID: 6137259
    [No Abstract]   [Full Text] [Related]  

  • 5. False-positive Waaler-Rose test in IgA deficiency.
    Hammarström L; Smith CI
    Scand J Rheumatol; 1985; 14(1):83-4. PubMed ID: 2860720
    [No Abstract]   [Full Text] [Related]  

  • 6. IgA deficiency during aurothioglucose treatment. A case report.
    van Riel PL; van de Putte LB; Gribnau FW; de Waal RM
    Scand J Rheumatol; 1984; 13(4):334-6. PubMed ID: 6441247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective and generalized hypogammaglobulinemia in patients with rheumatoid arthritis in treatment with gold salts].
    Bambara LM; Biasi D; Caramaschi P; Codella O; De Sandre G
    Ann Ital Med Int; 1986 Dec; 1(4):298-302. PubMed ID: 3275190
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulphasalazine in rheumatoid arthritis.
    McConkey B; Amos RS; Durham S; Forster PJ; Hubball S; Walsh L
    Br Med J; 1980 Feb; 280(6212):442-4. PubMed ID: 6102877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salazopyrin in rheumatoid arthritis.
    McConkey B; Amos RS; Butler EP; Crockson RA; Crockson AP; Walsh L
    Agents Actions; 1978 Jun; 8(4):438-41. PubMed ID: 28650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.
    Farr M; Waterhouse L; Johnson AE; Kitas GD; Jubb RW; Bacon PA
    Clin Rheumatol; 1995 Sep; 14(5):531-6. PubMed ID: 8549091
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good response to D-penicillamine in IgA-deficient rheumatoid arthritis.
    Mbuyi-Muamba JM; Stevens E; Dequeker J
    Scand J Rheumatol; 1981; 10(1):31-2. PubMed ID: 7221493
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulphasalazine in the treatment of rheumatoid arthritis.
    Pelísková Z; Vácha J; Trnavský K
    Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of the AIMS questionnaire in the evaluation of sulphasalazine treatment in rheumatoid arthritis.
    Pelísková Z; Trnavský K; Vácha J
    Z Rheumatol; 1987; 46(3):124-8. PubMed ID: 2442919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    Pullar T; Hunter JA; Capell HA
    Br J Rheumatol; 1985 Aug; 24(3):269-76. PubMed ID: 2861876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal IgA levels in patients with rheumatoid arthritis.
    Badcock LJ; Clarke S; Jones PW; Dawes PT; Mattey DL
    Ann Rheum Dis; 2003 Jan; 62(1):83-4. PubMed ID: 12480680
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Bax DE; Amos RS
    Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.